Manny Villafaña is a Puerto Rican-American medical-device entrepreneur based in Minnesota, born in 1940, and best known as the founder of St. For readers specifically looking for Manolo Villaverde net worth figures, this article explains why founder-equity and SEC-documented holdings matter more than automated guesses. Jude Medical and several other cardiac-device companies. His net worth today is most credibly estimated in the range of $20 million to $40 million, based on a 1999 Forbes figure of roughly $20 million and the continued equity stakes and founding roles he has held in multiple subsequent ventures, including Medical 21 and Kips Bay Medical. Some low-traffic aggregator sites publish figures as low as $2.3 million, but those numbers lack any documented sourcing and almost certainly undercount his equity holdings.
Manny Villafana Net Worth: Estimate, Breakdown, and How to Verify
Who Manny Villafaña is and why people search his wealth
Manny Villafaña (full name Manuel A. Villafaña) was born in 1940 in New York City to Puerto Rican parents and built a career that made him one of the most consequential figures in the history of cardiac medicine. He co-founded Cardiac Pacemakers Inc. (CPI) in 1971, then founded St. Jude Medical in 1976, a company that eventually became a multi-billion-dollar global medical-device leader. He went on to found CABG Medical in 2000 (which wound down in 2006), Kips Bay Medical in 2007, and most recently Medical 21, described in the Star Tribune and elsewhere as his eighth medical-device startup. He holds a Ph.D.Sc. and has been inducted into the Minnesota Science and Technology Hall of Fame. People search his net worth because serial medical-device founders who have taken companies public and through acquisitions can accumulate substantial wealth that is not always well-documented publicly, and because his Hispanic heritage makes him a notable figure for this type of financial research.
One quick disambiguation note: the name 'Manny Villafana' does not appear to be widely shared with another high-profile public figure, so the search almost certainly refers to this medical entrepreneur. He is distinct from other Hispanic business figures such as Manny Villar (the Filipino billionaire politician) whose wealth profile is a separate topic entirely.
The current net worth estimate: what the range looks like
The most defensible estimate for Manny Villafaña's net worth as of mid-2026 is $20 million to $40 million. For the latest context on the Manny Vivar net worth discussion and how estimates are formed, focus on verifiable equity disclosures rather than aggregator guesses net worth estimate. Because many readers search this figure as a peso amount, the same $20 million to $40 million range can be converted to pesos using the current exchange rate net worth in peso. Here is how that range breaks down and why it is set where it is.
The floor of roughly $20 million comes directly from a Forbes profile published on November 15, 1999, which explicitly stated that Villafaña 'has a net worth of some $20 million,' attributing it to the string of medical-device companies he had founded by that point. That is a hard data point from a credible outlet, not an algorithm-generated guess. The ceiling of roughly $40 million reflects plausible asset appreciation, additional equity stakes in Kips Bay Medical (a Nasdaq-listed company) and Medical 21 (which filed a roughly $21 million equity offering with the SEC in 2019), and general investment growth over more than two decades. It also accounts for the fact that no Forbes list or credible financial disclosure has placed him significantly above that range.
The PeopleAI figure of $2.3 million (published for February 2026) is almost certainly wrong. That site uses automated estimation models that frequently anchor on salary data or public tax records rather than founder equity, and they often dramatically undercount wealth held in company shares, trusts, or private investment vehicles. Villafaña's SEC filing for Medical 21 alone lists him as the beneficial owner of 8,720,000 common shares plus stock options, and even at a modest per-share valuation those holdings would exceed $2.3 million by a wide margin. Treat that figure as an unreliable outlier.
Where the money actually comes from
Founding equity and company exits
The core engine of Villafaña's wealth has always been founder equity in medical-device startups. St. Jude Medical, the company he founded in 1976, grew into a multi-billion-dollar enterprise before being acquired by Abbott Laboratories for roughly $25 billion in 2017. Villafaña's stake would have been substantially diluted through decades of venture rounds, public offerings, and executive compensation programs, but even small residual ownership at exit creates meaningful wealth. CPI, his earlier co-founded company, was also commercially successful. Forbes credited exactly this pattern of serial founding as the basis for the $20 million figure in 1999.
Kips Bay Medical and Medical 21
Villafaña founded Kips Bay Medical in 2007 and served as both Chairman of the Board and CEO since inception. Kips Bay listed on Nasdaq, which creates a publicly trackable share price and gives founder holdings a verifiable market value. Medical 21, his eighth company, filed an SEC offering circular for approximately $21 million in equity as early as 2019, with Villafaña identified as Founder and CEO and listed as the beneficial owner of a majority of the company's shares. The SEC filings also reference a legal vehicle called the 'Manuel A. Villafaña Revocable Trust Agreement,' which is how high-net-worth individuals typically hold company equity for estate-planning purposes. The existence of that trust structure signals a level of accumulated wealth worth formalizing into a trust, which is generally not done for small amounts.
Salary and compensation
As a founder-CEO of private and early-stage companies, Villafaña's salary at any given moment is not publicly disclosed. Executive compensation at founder-led medical startups is typically modest in early phases (often below $300,000 annually) but is supplemented heavily by stock options and equity grants. That means his annual cash income is likely less relevant to his total net worth than his equity positions.
What is likely excluded from public estimates
- Private real estate holdings: No public records or news articles document specific property ownership, but individuals with $20M+ in wealth typically hold meaningful real estate assets.
- Private investment portfolio: Decades of liquidity events (company sales, IPOs) likely funded a private investment or brokerage portfolio that is entirely opaque without tax returns or voluntary disclosure.
- Debt and liabilities: Trust structures and company equity can carry margin loans or other debt against them, which would reduce actual net worth below gross asset value.
- Undisclosed business interests: As a serial entrepreneur, Villafaña may hold advisory equity or small stakes in other med-tech companies that are not reported anywhere.
- Charitable giving and foundations: Some wealth may have been donated or placed in donor-advised funds, reducing taxable estate and therefore not appearing in net-worth estimates.
How net worth is calculated for someone like Villafaña
Net worth is simply total assets minus total liabilities. For a founder-entrepreneur, the biggest asset is usually equity in companies, which is relatively easy to estimate for public companies (shares times share price) and hard to estimate for private ones (requires a valuation assumption). Here is how a responsible estimate is built for someone like Villafaña.
- Start with the last confirmed public figure: Forbes 1999 = approximately $20 million.
- Identify equity events since then: Kips Bay Medical IPO, Medical 21 SEC offering, any disclosed share sales or grants.
- Estimate current market value of known equity: For Medical 21, use the offering price per share multiplied by Villafaña's disclosed share count (8,720,000 shares plus options). For Kips Bay, check Nasdaq-reported share price and ownership filings.
- Add a reasonable assumption for investment growth on prior liquidity: $20M invested or diversified over 25+ years at even a conservative 4-6% annual return would compound substantially.
- Subtract known liabilities where disclosed: company debts, personal loans, or trust encumbrances are rarely public, so this step often results in a range rather than a point estimate.
- Acknowledge what is missing: undisclosed real estate, private investments, and philanthropic transfers are blind spots in every external estimate.
This approach is why the estimate comes out as a range ($20M-$40M) rather than a single number. Anyone publishing a precise figure like '$2.3 million' or '$35 million' without citing verifiable sources is either guessing or using a model that was not built for founder-equity situations.
Wealth timeline: how his fortune built up (and shifted) over decades
| Period | Key Event | Estimated Wealth Impact |
|---|---|---|
| 1971–1975 | Co-founds Cardiac Pacemakers Inc. (CPI) | Early equity stake; CPI becomes commercially viable; likely modest initial liquidity |
| 1976–1990s | Founds St. Jude Medical; company grows into major public medical-device firm | Substantial equity appreciation over time; stake heavily diluted but still meaningful at scale |
| 1999 | Forbes profile explicitly cites net worth of ~$20 million | Confirmed baseline figure — most reliable anchor point in the public record |
| 2000–2006 | Founds CABG Medical; company closes in 2006 | Limited or no liquidity event; possible loss of invested capital or time cost |
| 2007–2018 | Founds Kips Bay Medical; serves as Chairman/CEO; company lists on Nasdaq | Publicly trackable equity; founder shares create verifiable wealth component |
| 2017 | Abbott acquires St. Jude Medical for ~$25 billion | Any residual or vested St. Jude equity would have been monetized; amount not publicly disclosed |
| 2019 | Medical 21 files SEC offering for ~$21M; Villafaña listed as majority beneficial owner | Equity stake in Medical 21 valued at offering-stage prices; exact amount depends on offering completion and valuation |
| 2022–2026 | Medical 21 continues development as eighth medical startup | Wealth largely illiquid (tied to private company equity); no confirmed public exit or IPO yet |
The overall trajectory is one of compounding founder equity across multiple companies, with the most reliable external snapshot being the 1999 Forbes figure. The gap between 1999 and today is the main uncertainty zone: there have been active company formations and at least one major industry exit (Abbott/St. Jude), but no updated credible public figure has been published by Forbes or a comparable outlet since then.
Common rumors, conflicting numbers, and how to fact-check them
The biggest source of confusion around Villafaña's net worth is the low-end figures circulated by automated aggregator sites. Sites like PeopleAI, Celebrity Net Worth clones, and similar platforms often publish numbers in the $1M-$5M range for business figures who are not household names. These sites typically scrape salary databases, LinkedIn-adjacent data, or simply assign a default low estimate when no celebrity-level coverage exists. They are not accounting for founder equity, revocable trusts, or multi-decade company stakes. If you see a figure below $10 million for Villafaña, that is a red flag that the source is using an unreliable methodology.
Another common confusion: some searches for 'Manny Villafana net worth' may surface results mixed with Manny Villar, the Filipino billionaire and former senator whose wealth is in the billions of pesos. If you meant Vivian Yuchengco instead, her net worth in peso values are usually discussed separately and can differ significantly from Manny Villafaña’s Vivian Yuchengco net worth in peso. These are completely different people. Manny Villar's financial profile is a separate topic with entirely different sourcing and magnitude.
To fact-check any Villafaña wealth claim yourself, here is what to do. First, go to SEC.gov and search for 'Medical 21' in the EDGAR full-text search. Pull the Regulation A offering circular and look at the beneficial ownership table, it will show you Villafaña's share count directly. Second, check Nasdaq or SEC filings for Kips Bay Medical (ticker: KBSY) for any insider ownership disclosures. Third, search the Forbes.com archive for the 1999 article titled 'A Boy's Story' to confirm the $20 million baseline figure. Any estimate that contradicts all three of those sources without providing new primary documentation should be treated skeptically.
How to find the most current, credible updates going forward
Villafaña's wealth is closely tied to private company milestones, so the events most likely to change his net worth estimate are also the ones worth monitoring. Here is what to watch.
- Medical 21 IPO or acquisition: If Medical 21 goes public or is acquired, founder equity becomes liquid and publicly priced. Watch SEC EDGAR for new S-1 or Regulation A filings, and watch MassDevice or MedCity News for deal announcements.
- Kips Bay Medical insider filings: As a Nasdaq-listed company, Kips Bay must file Form 4s (insider trading disclosures) whenever Villafaña buys or sells shares. These appear on SEC EDGAR within two business days of a transaction.
- Credible media profiles: The Star Tribune has covered Villafaña multiple times given his Minnesota roots. A new profile there or in Forbes, Fortune, or trade publications would be the most reliable place for an updated wealth figure.
- Trust and estate disclosures: The Manuel A. Villafaña Revocable Trust is already identified in SEC filings. If this trust ever appears in probate, charitable gift, or real estate transaction records, it could reveal asset levels.
- Lawsuits or regulatory actions: Patent disputes, SEC enforcement actions, or business litigation can sometimes surface asset or liability information that is otherwise private.
- Tax lien searches: Public tax lien records in Minnesota (Hennepin or Ramsey County) can indicate financial stress or large settlements, though the absence of liens is not by itself confirmation of wealth.
For ongoing tracking, the most reliable approach is to bookmark Villafaña's SEC EDGAR page (search his name as an officer/director), set a Google News alert for 'Manny Villafaña Medical 21,' and check this site's profile page for updated estimates as new data becomes available. Net worth profiles for business founders are inherently dynamic because private equity values change with each funding round or business milestone, so treating any single number as permanently accurate is a mistake regardless of the source.
FAQ
How can I verify Manny Villafana’s wealth from primary documents if much of it is private equity?
Look for “beneficial ownership” tables (and any amendments) in EDGAR documents, not company press releases. Beneficial ownership clarifies share count plus stock options, and it is usually the most defensible starting point for valuing founder equity.
When estimating Manny Villafana net worth from SEC filings, how do I handle stock options and dilution?
Beneficial ownership can include options and performance-based grants. To avoid overcounting, separate “common shares” from “options/warrants,” then apply a valuation assumption only to the portion that could be exercised or sold.
What exchange rate should I use when converting Manny Villafana net worth into pesos?
A peso conversion is only as accurate as the underlying USD estimate and the exchange rate date. If you convert $20M to $40M, use the same mid-market rate and specify whether you want the conversion as of a particular day (not an average).
Could an acquisition like St. Jude Medical change Manny Villafana net worth after the deal is announced?
Yes, a big sale or acquisition can change net worth in ways that are not fully captured by later public filings. If a company was acquired, check whether the founder received cash at closing, rolling equity, or earn-out structures, since earn-outs may pay years later.
Why do some websites show Manny Villafana net worth that looks like it belongs to a different person?
Be careful with account names. Some sites misspell “Villafaña” or swap results with similarly named people. Cross-check the location and role (founder, CEO, chairman) and the associated company names (St. Jude, Medical 21, Kips Bay) before trusting any number.
How often should Manny Villafana’s net worth estimate be updated, and what date should I reference?
If there is a recent SEC filing, prioritize updated ownership data over older estimates. For time sensitivity, treat the net worth figure as “as-of” the filing date, because valuation and share price can move between filings.
What red flags indicate an unreliable Manny Villafana net worth estimate?
Aggregator sites sometimes anchor to salary or “public figure” templates, which can massively understate founder equity. If you see a figure well below $10 million, check whether the source explains its methodology and whether it accounts for share holdings and trust vehicles.
Do net worth estimates for founders like Manny Villafana consider liabilities accurately?
For founders, liabilities can include taxes due on equity events and margin loans tied to holdings. Public net worth articles rarely model liabilities well, so the range should be treated as assets-first unless there is explicit disclosure about debts.
What specific events are most likely to move Manny Villafana’s net worth estimate up or down?
The most meaningful “next numbers” usually come from new offerings, insider transaction forms, or updated ownership disclosures. In particular, monitor any SEC filings where Medical 21 or successor ventures mention him as officer/director or beneficial owner.
How should I reconcile the 1999 Forbes baseline with later SEC-based numbers to avoid mixing estimates?
Don’t rely on a single article or a single year of a Forbes snapshot. Instead, confirm the baseline (for example, the 1999 figure) and then reconcile any later public filings for owned shares or equity offerings that suggest new valuation. If later primary sources conflict, update the range rather than average in the guess.
Estimate of Manolo Villaverde net worth with sources, method, income sources, range, assumptions, and how to verify.
Net worth estimate of Manny Villar with explained methodology, assets and liabilities, and how to verify updates over ti
Estimate of Federico Fede Valverde net worth, key Real Madrid income, and why values vary over time.